Richard S Levy Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Richard S Levy.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Richard S Levy. Richard S Levy is EVP, Chief Drug Dev&Medical Of in INCYTE CORP ($INCY).

Latest Insider Trading Transactions of Richard S Levy

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 18 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.728,317122,4260
Feb 18 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM17.793,68365,52190,217
Feb 18 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS76.9012,000922,80018,20530.2 K to 18.2 K (-39.73 %)
Feb 18 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.728,317122,42630,20521.9 K to 30.2 K (+38.00 %)
Feb 18 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM17.793,68365,52121,88818.2 K to 21.9 K (+20.23 %)
Feb 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.3225,000458,00091,782
Feb 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS75.1125,0001,877,75018,20543.2 K to 18.2 K (-57.86 %)
Feb 10 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.3225,000458,00043,20518.2 K to 43.2 K (+137.32 %)
Jan 20 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.7212,000176,6408,317
Jan 20 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS73.0712,000876,84018,20530.2 K to 18.2 K (-39.73 %)
Jan 20 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.7212,000176,64030,20518.2 K to 30.2 K (+65.92 %)
Jan 09 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA73.211,08579,4331,085
Jan 09 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseA73.2120,4601,497,87720,460
Jan 09 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...GrantA0.003,022021,22718.2 K to 21.2 K (+16.60 %)
Jan 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM18.3225,000458,000116,782
Jan 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS71.8425,0001,796,00018,20543.2 K to 18.2 K (-57.86 %)
Jan 08 2015INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM18.3225,000458,00043,20518.2 K to 43.2 K (+137.32 %)
Dec 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.7212,000176,64020,317
Dec 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS72.3612,000868,32018,20530.2 K to 18.2 K (-39.73 %)
Dec 18 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.7212,000176,64030,20518.2 K to 30.2 K (+65.92 %)
Nov 19 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...Option ExerciseM14.7212,000176,64032,317
Nov 19 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...SellS69.9712,000839,64018,20530.2 K to 18.2 K (-39.73 %)
Nov 19 2014INCYINCYTE CORPLevy Richard SEVP, Chief Drug Dev ...BuyM14.7212,000176,64030,20518.2 K to 30.2 K (+65.92 %)

Page:   1